US › Healthcare

PetMed Express Inc (PETS)

US · Healthcare · Pharmaceutical Retailers

$1.99+0.25%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$42.8M
Revenue YoY
-19.2%
Net profit
$-4.1M
Profit YoY
-474.4%
EPS
$-0.19
EPS estimate
$-0.18
Net margin
-9.5%

EPS came in at -0.19 against a street estimate of -0.18 — a miss of 5.6%.

Key statistics

Market cap
$41.7M
Forward P/E
16.7
P/B
1.44
Book value
$1.38
EPS (TTM)
$-2.74
52-week high
$4.10
52-week low
$1.57
50-day MA
$1.94
200-day MA
$2.45
Beta
0.78

Analyst view

Analysts rate PetMed Express Inc a sell (0 buy, 1 hold, 1 sell out of 2) with an average price target of $2.15.

Shareholding

Insiders
15.57%
Institutions
44.62%

Largest institutional holders

FundStake
Renaissance Technologies Corp5.55%
Vanguard Group Inc4.51%
Vanguard Capital Management, LLC3.89%
Federated Hermes Inc3.12%
BlackRock Inc2.58%
Hotchkis & Wiley Capital Management LLC2.41%
UBS Group AG1.09%
Geode Capital Management, LLC1.04%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for PetMed Express Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.